
European regulators cleared on Tuesday a takeover in the pharmaceutical sector worth 9.6 billion euros ($13.6 billion) by Japanese firm Takeda Pharmaceutical of Swiss drugmaker Nycomed. The European Commission announced its approval after tests showing that the combined market share of Takeda and Nycomed in Austria, Germany and Italy, where they both sell proton pump inhibitors (PPIs), drugs used in treating ulcers and other stomach acid disorders, "is not very high." The deal was agreed in May during a series of acquisitions for Japanese firms looking to make the most of a strong yen and offset limitations in a shrinking home market. Best-known for its Actos diabetes treatment, Takeda is Japan's biggest drugmaker by revenue.
GMT 17:56 2018 Wednesday ,17 January
Ericsson to write down 1.4 billion euros in fourth quarterGMT 19:16 2018 Saturday ,13 January
China shuts Marriott website over Tibet error, scolds other firmsGMT 17:31 2018 Thursday ,11 January
UK group bids for Europe's biggest aluminium smelterGMT 17:24 2018 Thursday ,11 January
UK supermarket Sainsbury's lifts outlook after bumper ChristmasGMT 17:52 2018 Tuesday ,09 January
H&M removes 'black boy' ad after racism accusationGMT 19:38 2018 Wednesday ,03 January
Petrobras pay $2.95bn to settle US class action on corruptionGMT 13:49 2018 Wednesday ,03 January
China’s Ant Financial drops $1.2 billion MoneyGram deal as US approval failsGMT 17:47 2017 Sunday ,31 December
BA owner to buy bankrupt Austrian airline Niki
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor